Chirag Jani

TL;DR: In this paper, patients with triple-negative breast cancer (TNBC) and residual invasive disease (RD) after completion of neoadjuvant chemotherapy (NAC) have a high risk for recurrence.

TL;DR: A case of false positive PET/CT and FDG scan in a patient with fat necrosis mimicking B-cell lymphoma after 6 cycles of rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone treatment is described.

TL;DR: Early dynamic PET/CT and 18F-FDG scans were performed on 7 consecutive male patients with pathology-confirmed bladder cancer as mentioned in this paper, where a series of 5 dynamic scans of 2 minutes each, starting at injection time, were obtained on each patient's urinary bladder.

TL;DR: Early dynamic FDG PET images can demonstrate bladder lesions that are obscured by urine activity on routine images at 1 hour, as well as identify bladder cancer using a novel PET/CT and 18F-FDG scanning protocol that takes advantage of the angiogenesis observed in malignancies and the kidneys' physiology of delayed excretion into the urinary bladder.

TL;DR: In this paper, the authors estimated the rate of false positive PET/CT and 18F-NaF scans when performed to assess bone lesions and found that most false positive instances were observed in the joints and areas of degenerative changes particularly in long/short bones and spine.